Arthritis, Juvenile
Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.
Drugs by status
Approved for this indication (17)
Phase 4 trials (13)
Phase 3 trials (27)
- 23-valent pneumococcal polysaccharide vaccine
- vitamin d3
- secukinumab
- bimekizumab
- apremilast
- certolizumab pegol
- golimumab
- tofacitinib
- entecavir
- somatropin
- guselkumab
- hydroxychloroquine
- calcium
- baricitinib
- ixekizumab
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- adalimumab
- lidocaine
- risankizumab
- ustekinumab
- live, attenuated, dengue serotype 1, 2, 3, 4 virus
- infliximab
- upadacitinib
- anakinra
- emapalumab-lzsg
- ubiquinone
- deucravacitinib
Phase 2 trials (16)
Other trials (17)
- cyclosporine
- cyclophosphamide
- Anti-thymocyte Globulin (Rabbit)
- yellow fever vaccine 17d strain
- ondansetron
- bifidobacterium infantis
- bifidobacterium breve
- bifidobacterium longum
- lactobacillus plantarum
- vsl #3
- streptococcus salivarius
- autologous mononuclear stem cell
- sargramostim
- dihomo-gamma-linolenic acid
- Lactobacillus acidophilus
- lactobacillus casei
- lactobacillus delbrueckii
Organizations
Organization Involved with Phase 4 Indications (22)
- Horizon Pharma
- Amgen
- Pfizer
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Maastricht University
- University of Washington
- Mashhad University of Medical Sciences
- Norwegian University of Science and Technology
- University Hospital of North Norway
- University of Groningen
- University of Oslo
- Utrecht University
- University of Bergen
- Sohag University
- University of Cincinnati
- Free University of Amsterdam
- University of Sao Paulo
- Erasmus University Rotterdam
- Dutch Arthritis Association
- Government of Norway
- National Institute for Public Health and the Environment, RIVM, Holland
Organization Involved with Phase 3 Indications (47)
- Swedish Orphan Biovitrum
- Abbott
- AbbVie
- Eisai
- Centocor
- Eli Lilly
- Chugai
- National Eye Institute (NEI)
- Ajou University
- Dong-A University
- Duke University
- Gachon University
- Hanyang University
- Hoosier Cancer Research Network
- Institut National de la Santé Et de la Recherche Médicale, France
- Korea University
- Kyung Hee University
- Ohio State University
- Rheumatism Foundation Hospital
- Seoul National University
- University of Adelaide
- Yonsei University
- Chonbuk National University
- Daegu Catholic University
- Chungnam National University
- University of Missouri
- Konkuk University
- Pharmaceutical Research Associates, Inc. (PRA)
- Catholic University of Korea
- Eulji University
- +17 more
Organization Involved with Phase 2 Indications (22)
- AB2 Bio Ltd.
- Regeneron
- Genentech
- Sanofi
- Italfarmaco
- NovImmune SA
- The EMMES Corporation
- Bnai Zion Medical Center
- Indiana University
- Oregon Health and Science University
- University of Tampere
- Tel Aviv University
- University of Turku
- Uppsala University
- Technion University
- Kuopio University Hospital
- Linkoping University
- Humboldt University
- Government of Finland
- University of Stavanger
- Yeshiva University
- University of Geneva
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (22)
- PPD
- Parexel
- University of Manitoba
- McGill University
- McMaster University
- Memorial University of Newfoundland
- Tufts University
- University of Oklahoma
- University of Ottawa
- University of Toronto
- University of Bath
- Dalhousie University
- University of British Columbia
- University of Calgary
- Food and Drug Administration
- University of Minnesota
- University of Montreal
- University of Massachusetts
- University of Western Ontario
- The Arthritis Society, Canada
- Medac
- The University of Texas, Dallas